if you look the disease progression (PD) was 0%... short time frame to predict anything but...
partial response was 36% ? means reduction in tumour size with abraxane combo ?
definitely great results but market will need time
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer, page-8
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $43.96M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.0¢ | $33.10K | 209.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 70000 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 30808 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |